Private Advisor Group LLC Purchases Shares of 25,993 Livent Co. (NYSE:LTHM)

Private Advisor Group LLC bought a new stake in Livent Co. (NYSE:LTHMFree Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 25,993 shares of the company’s stock, valued at approximately $565,000.

A number of other hedge funds and other institutional investors have also modified their holdings of LTHM. US Bancorp DE increased its position in shares of Livent by 46.5% in the first quarter. US Bancorp DE now owns 21,176 shares of the company’s stock valued at $552,000 after acquiring an additional 6,726 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its position in shares of Livent by 27.4% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 20,285 shares of the company’s stock valued at $529,000 after acquiring an additional 4,359 shares during the last quarter. HighTower Advisors LLC increased its position in shares of Livent by 18.1% in the first quarter. HighTower Advisors LLC now owns 39,483 shares of the company’s stock valued at $1,033,000 after acquiring an additional 6,044 shares during the last quarter. PNC Financial Services Group Inc. increased its position in shares of Livent by 7.5% in the first quarter. PNC Financial Services Group Inc. now owns 39,016 shares of the company’s stock valued at $1,017,000 after acquiring an additional 2,726 shares during the last quarter. Finally, MetLife Investment Management LLC increased its position in shares of Livent by 53.9% in the first quarter. MetLife Investment Management LLC now owns 86,337 shares of the company’s stock valued at $2,251,000 after acquiring an additional 30,254 shares during the last quarter. Institutional investors and hedge funds own 96.76% of the company’s stock.

Livent Trading Up 0.9 %

Shares of NYSE:LTHM opened at $21.67 on Friday. Livent Co. has a 12-month low of $18.26 and a 12-month high of $36.38. The stock has a market cap of $3.89 billion, a PE ratio of 12.45, a P/E/G ratio of 0.28 and a beta of 1.81. The business has a 50 day moving average of $24.84 and a 200-day moving average of $23.82. The company has a quick ratio of 2.37, a current ratio of 3.76 and a debt-to-equity ratio of 0.15.

Livent (NYSE:LTHMGet Free Report) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.05. The business had revenue of $235.80 million during the quarter, compared to analysts’ expectations of $257.00 million. Livent had a return on equity of 26.79% and a net margin of 38.85%. As a group, equities research analysts forecast that Livent Co. will post 2.15 earnings per share for the current year.

Analysts Set New Price Targets

LTHM has been the subject of a number of research analyst reports. HSBC reduced their price target on Livent from $37.00 to $33.50 in a report on Friday, June 23rd. Piper Sandler reduced their price target on Livent from $38.00 to $33.00 and set an “overweight” rating for the company in a report on Friday. B. Riley upgraded Livent from a “neutral” rating to a “buy” rating and set a $32.00 price target for the company in a report on Thursday, May 11th. Finally, KeyCorp reduced their price target on Livent from $35.00 to $34.00 and set an “overweight” rating for the company in a report on Friday, August 4th. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $29.95.

View Our Latest Stock Report on LTHM

Livent Profile

(Free Report)

Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications.

Recommended Stories

Want to see what other hedge funds are holding LTHM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Livent Co. (NYSE:LTHMFree Report).

Institutional Ownership by Quarter for Livent (NYSE:LTHM)

Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.